​

Funding Round

Series A - AIRNA

Series A - AIRNA

Investment Firm

Overview

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

Announced Date

Jul 31, 2024

Closed on Date

Jul 31, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Forbion Capital Partners

Forbion Capital Partners

Forbion Capital Partners is a early_stage_venture and post_ipo and seed firm.

Participant Investors

5

Investor Name
Participant InvestorOno Venture Investment
Participant InvestorAlexandria Venture Investments
Participant InvestorForbion Capital Partners
Participant Investor+ND Capital
Participant InvestorARCH Venture Partners

Round Details and Background

AIRNA raised $60000000 on 2024-07-31 in Series A

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 19, 2023
Series A - AIRNA
5-30.0M
Jul 31, 2024
Series A - AIRNA
5-60.0M

Recent Activity

There is no recent news or activity for this profile.